advertisement
Combrink KD 1
Showing records 1 to 1 | Display all abstracts from Combrink KD56525 In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma
Chen HH; Namil A; Severns B; Ward J; Kelly C; Drace C; McLaughlin MA; Yacoub S; Li B; Patil R; Sharif N; Hellberg MR; Rusinko A; Pang IH; Combrink KD
Bioorganic and Medicinal Chemistry Letters 2014; 24: 1875-1879
